NOT-CA-21-007: Notice of Extension of the Expiration Date for PAR-18-530 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01

Notice of Extension of the Expiration Date for PAR-18-530 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)"

Notice Number:

NOT-CA-21-007

Key Dates

Release Date:

November 4, 2020

Related Announcements

PAR-18-530 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for Funding Opportunity Announcement PAR-18-530 " Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 Clinical Trial Optional)" will be extended by one receipt date. This FOA now expires on May 8, 2021.

The following section in Part 1. Overview Information, Key Dates of PAR-18-530, has been changed (in italics):

Currently Reads:

Expiration Date: January 8, 2021

Revised to Read:

Expiration Date: May 8, 2021

NOTE: All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Miguel R. Ossandon, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5714
Email: [email protected]